Web10 jan. 2024 · Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations … Web21 nov. 2024 · Buying EastHORN would be expected to increase Novotech’s size - in terms of revenue and services - by about 15 per cent. However, the big thing from Novotech’s perspective, and that of its shareholders, is about entering a new geography.Europe is one of the missing links in Novotech’s existing footprint.
The Asia Pacific Centred Global Biotech CRO Novotech …
Web19 uur geleden · Novotech has recently acquired EastHORN a European CRO with clinical, ... Novotech has over 3,000 staff globally and 34 office locations across the US, Europe … WebNovotech expansion to Europe. As part of our global expansion program, EastHORN, a European CRO joined Novotech in January 2024 which means biotech clients can now … defined benefit income tool
Novotech Acquires European CRO – Strengthens Global Operations
Web20 nov. 2024 · Buying EastHORN would be expected to increase Novotech’s size - in terms of revenue and services - by about 15 per cent. However, the big thing from Novotech’s … WebEastHORN is now a Novotech company and will integrate all systems and processes, so clients benefit from working with one CRO globally. Experienced in Phase I to Phase IV studies across all therapeutic areas including Neurology & Psychiatry, Oncology, Cardiovascular Diseases, Infectious & Parasitic Diseases and Gastrointestinal Diseases. Web9 jan. 2024 · SINGAPORE, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically ... feeling breathless